DE2135259A1 - - Google Patents
Info
- Publication number
- DE2135259A1 DE2135259A1 DE19712135259 DE2135259A DE2135259A1 DE 2135259 A1 DE2135259 A1 DE 2135259A1 DE 19712135259 DE19712135259 DE 19712135259 DE 2135259 A DE2135259 A DE 2135259A DE 2135259 A1 DE2135259 A1 DE 2135259A1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- dissolving agent
- agent according
- carbonate
- basic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 6
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical group CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- OCHFNTLZOZPXFE-JEDNCBNOSA-N carbonic acid;(2s)-2,6-diaminohexanoic acid Chemical compound OC(O)=O.NCCCC[C@H](N)C(O)=O OCHFNTLZOZPXFE-JEDNCBNOSA-N 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 230000000622 irritating effect Effects 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 125000005587 carbonate group Chemical group 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7034991A FR2105111B1 (enExample) | 1970-09-28 | 1970-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2135259A1 true DE2135259A1 (enExample) | 1972-03-30 |
Family
ID=9061944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712135259 Pending DE2135259A1 (enExample) | 1970-09-28 | 1971-07-14 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE769896A (enExample) |
| DE (1) | DE2135259A1 (enExample) |
| FR (1) | FR2105111B1 (enExample) |
| GB (1) | GB1321419A (enExample) |
| IL (1) | IL37349A (enExample) |
| NL (1) | NL7110336A (enExample) |
| ZA (1) | ZA714785B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215950A2 (en) * | 1973-02-01 | 1974-08-30 | Union Pharma Scient Appl | Carbonated lysine - as carbonate source in effervescent compositions |
| CA1029660A (en) * | 1973-06-01 | 1978-04-18 | Kyowa Hakko Kogyo Co. | Prevention of gastric lesions |
| FR2547501A1 (fr) * | 1983-06-15 | 1984-12-21 | Opochimiotherapie Lab | Excipient effervescent, sans alcalino-terreux, contenant des composes carbonates de l'arginine et un acide, et comprimes effervescents correspondants |
| FR2746643B1 (fr) * | 1996-04-01 | 1998-06-12 | Techni Pharma | Nouvelles compositions laxatives et leur procede de fabrication |
| BRPI0906465A2 (pt) * | 2008-02-08 | 2015-07-14 | Colgate Palmolive Co | Composição efervesente, e, método |
-
1970
- 1970-09-28 FR FR7034991A patent/FR2105111B1/fr not_active Expired
-
1971
- 1971-07-12 BE BE769896A patent/BE769896A/xx unknown
- 1971-07-14 DE DE19712135259 patent/DE2135259A1/de active Pending
- 1971-07-19 ZA ZA714785A patent/ZA714785B/xx unknown
- 1971-07-20 IL IL37349A patent/IL37349A/xx unknown
- 1971-07-27 NL NL7110336A patent/NL7110336A/xx unknown
- 1971-09-28 GB GB4516771A patent/GB1321419A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1321419A (en) | 1973-06-27 |
| IL37349A0 (en) | 1971-10-20 |
| FR2105111A1 (enExample) | 1972-04-28 |
| FR2105111B1 (enExample) | 1974-03-22 |
| IL37349A (en) | 1974-06-30 |
| BE769896A (fr) | 1971-11-16 |
| ZA714785B (en) | 1972-04-26 |
| NL7110336A (enExample) | 1972-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES403435A1 (es) | Metodo para la preparacion de una composicion farmaceutica de liberacion lenta. | |
| ATE5125T1 (de) | Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren. | |
| IL47656A0 (en) | Sulphonic acid salts of s-adenosilmethionine,their preparation and pharmaceutical compositions containing them | |
| ATE49886T1 (de) | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung. | |
| FR2408345A1 (fr) | Nouvelle composition a action anti-conceptionnelle | |
| ES370058A1 (es) | Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes. | |
| DE2135259A1 (enExample) | ||
| US3621094A (en) | Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts | |
| DE2515594C3 (de) | Verfahren zur Herstellung eines stabilen, topisch aktiven Geles | |
| US3345264A (en) | Methods of suppressing anxiety employing sodium and iron salts of pyrrolidone carboxylic acid | |
| DE3545201A1 (de) | Synergistische kombination von flupirtin und 4-acetamido-phenol | |
| BE792803A (fr) | Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant | |
| DE651597C (de) | Verfahren zur Darstellung haltbarer Hormonpraeparate | |
| US2100054A (en) | Anesthetic tannate | |
| US1183055A (en) | Bromin solution. | |
| US3164519A (en) | Antacid composition and method of using same | |
| DE2523394A1 (de) | Pharmazeutische zubereitung | |
| AT356277B (de) | Verfahren zur herstellung waesseriger injektionsloesungen mit einem gehalt an valproinsaeure | |
| DE1617433C (de) | Verfahren zur Herstellung von 5,5 Diphenyl hydantoin Natrium Losungen fur Injektionszwecke | |
| Rang | Tinctura Iodi Decolorata | |
| Gear, JHS,**** Yeo, RM**** & Bodenstein | The aetiology of onyalai | |
| DE2619756A1 (de) | Pharmazeutische zubereitungen von penicillinverbindungen zum rektalen gebrauch | |
| GB191010062A (en) | Composition for Arresting and Preventing the Decay of Teeth. | |
| US2790746A (en) | Anti-rheumatic mixture and method of preparing | |
| US1404673A (en) | Preparations of medicinal substances and method of making the same |